Syros Pharmaceuticals
- Pharmaceutical Preparations
- Cambridge, Massachusetts
Compensation history
Top executives at Syros Pharmaceuticals received an average of $2M per person in annual compensation from 2015 to 2023.
Average pay of disclosed executives at Syros Pharmaceuticals
By year
Executives
We found eight executives who work or worked at Syros Pharmaceuticals.
Nancy Simonian
Syros Pharmaceuticals
Chief Executive Officer
Eric Olson
Syros Pharmaceuticals
Chief Scientific Officer
David Roth
Syros Pharmaceuticals
Chief Medical Officer
Jason Haas
Syros Pharmaceuticals
Chief Financial Officer
Joseph Ferra
Syros Pharmaceuticals
Chief Financial Officer
Jeremy Springhorn
Syros Pharmaceuticals
Chief Business Officer
Kyle Kuvalanka
Syros Pharmaceuticals
Chief Operating Officer
Gerald Quirk
Syros Pharmaceuticals
Chief Legal Officer
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019
About Syros Pharmaceuticals
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address35 Cambridge Park Drive, Cambridge, Massachusetts 02140
- Phone617-744-1340
- Fiscal year endDecember 31
- Former names
- LS22, Inc.Until August 21, 2012
Source: SEC filings on April 23, 2024, April 21, 2023, April 21, 2022, April 29, 2021, April 28, 2020, April 25, 2019, April 26, 2018, and April 25, 2017.